Member Info for CHELSEA7

Yes. That was Tuesday, have cancelled Level 2, lets say i have some strong feelings about LSE. Kept my membership open, despite my feelings, will post rarely, very rarely but as i was just sharing some information which hasn"t been posted.

Don"t want to say much more about that, it is getting harder for me just to get through the day, but the personals have been for some time far too much for even me. Take care buddy, just time i moved on. A shame really there is so much to discuss and so many good posters, not to mention so many who just won"t post here anymore. Hope it gets better, i really do.

Good news for them and hopefully good news for us.

https://www.fiercebiotech.com/biotech/pfizer-pays-biontech-120m-to-form-mrna-flu-vaccine-pact?mkt_tok=eyJpIjoiWXpkbU9EQTJOR1psT0dReSIsInQiOiI1UUxkRWIydGkyYm93YWdTTG9DOHNZd2dEaURqVmNoVVNlV3JVaU9HU043Q0ZyQlNFckdkU0Nzdm84YUZ5UXk0ejM2dmxDM3hsMld3dUc3K1g0dHNRaXRIZUl4VnZRZ0V2Z1dBblBQMlZEV285OWJCdGhGTGZ2ODlcL1ZRQ1BhbXQifQ%3D%3D&mrkid=36433381

From yesterday morning at 11.34 that 200k trade bid has been rising slowly since.

Cancelled my level 2 on Tuesday, still paid for till 28th, can"t believe how quick they were to remove my red badge. Mutually says it all, lol.

Surprises me a bit that bigger trades aren"t posted.

Just noticed another 50k buy at 11.8p and a 200k trade at 11.50. Prefer not to call those as buys or sells. Know what i think, and it does confirm that lately there have big some much bigger trades. Never thought getting away from 11/12 would be that easy, but notable all the same. Wonder if Thursdays RNS about Karolinska is being read as i saw it, further validation of our platforms.??

Inanaco, I did not ask you to justify anything.

Obviously the more you understand about the Science and what is going on elsewhere elements of risk are shortened.

I have always argued that risk is different for everybody, without risk i would never have opened twenty odd companies, just three failed. But the bank always backed me, they work on risk too. and did well out of me.

I just don"t need what i have put in here, but have never said anything but a success would make my life significantly easier, but in my circumstances it becomes harder to see where.

So risk, is different to each, a better understanding reduces perceived risk, but there is risk as our SP has proved.

Inanaco, as an observer here now, I just recced your 13.04.

I do think it is totally relevant to all of us, whether we will have to wait for a financial commercial deal, none of us know. I know in one of my last posts i said SCLP doesn"t worry me as much as the AIM market does, each will take that as they see fit.

As an observer, and will always read posts here for my information whether good or bad, the problem is the same. The reason i thanked you for all the good stuff was very sincere, it still sadly invites far too much debate over the term "risk".

I doubt anybody disagrees with your 13.04 post, but i understand the furore that "no risk" has created.

It is up to you not to justify that, but to end it finally. There is considerable risk, and i note that out of 150 trials CRUK have undertaken just 4/5 have gone commercial, so far. That is about a 3% success rate. There indeed is the risk for all, and bigger companies than us. You are far too intelligent to let this carry on, it rather negates so much you say that many agree with.

Wish you all well.

That drunken rant from TF reminds me why I choose to ignore him.

You said..........well let me see Scancell sits above Genentech, ISA pharma, and BioNtech in the Grand Challenge which is based around a Modi 3 ... so even Genentech does not have the product to lead this, Try and get your head around what is going on here !!

I said............"".Correct inanaco, been saying that.""" I trust you were saying as i have re Thursdays RNS and the Grand Challenge, and the company Scancell keep a very simple ""open our eyes"", which i am sure those seeing the bigger picture do. I also wanted to thank you for the good stuff you have done here.

I added which TF wouldn"t understand............... you have done a great job here.................but often people feel they are blinded by the science, rater than enpowered by it. We aren"t all oncologists really.

Anyway take care and everybody, got a lot to do with me for now. Be lucky!!!

I wanted to part with that thank you. Unfortunately my health is rapidly deteriorating, the posts (like TF) are becoming more toxic, so will further treatment. We had many a laugh, i prefer to remember that. I am hoping to go to the AGM still, who knows. look forward to meeting whoever is there.

But sincere thanks to everybody here, you have all taught me something, and the best of luck to all.

No, you have done a great job here.................but often people feel they are blinded by the science, rater than enpowered by it. We aren"t all oncologists really.

Anyway take care and everybody, got a lot to do with me for now. Be lucky!!!

Correct inanaco, been saying that. Cancelled my level2 today, membership next, ADMIN allow too much to go on IMHO.........stuff that is obvious to most.

Agree about Project Fear inanaco, but thats why they do what they do. For some it works when repeated.

Agree with ratty too. Like i said no big deal now.

380k reasons why you are wrong.

Agreed it has been RNSed, but the IND should have been end H1. just leaves room for doubt.. No big deal, but buys and big ones are coming in.

Yep

Mind you, damn good news, lol.

Should tick up soon, have a good day.

And all Scancell had to do was issue a RNS Reach to confirm SCIB1, GIVEN THE IND deadline had elapsed, and told us of the status of SCIB2.

That is what i call considering shareholders!!

Volume 290k

Buys 289k

Buys 222k

Sells 1k

https://pharmaphorum.com/news/scancell-expands-cancer-research-deal-karolinska/

SCANCELL Retweeted

pharmaphorum
‏

@pharmaphorum
Aug 10
More
UK #immunotherapy #biotech @scancellpharma expands #cancer research deal with @karolinskainst - http://bit.ly/2vV913f

Thanks botski..........................

SCANCELL Retweeted

John Glencross
‏

@GlencrossJohn
15m15 minutes ago
"""More
Good chat with Cliff Holloway, CEO of @scancellpharma, this morning. The SCIB1 combo trial previously announced by the company is on track with those sites already selected expected to initiate the study by year end as planned."""

We did discuss it. I did a few times. What nonsense....................Day 2!!!

The BB can discuss different threads, but interesting nobody joined in after it was discussed.

https://www.investegate.co.uk/motif-bio-plc--mtfb-/rns/fda-acceptance-of-new-drug-application/201808140700096791X

Well done you guy, GL Ivy